Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
METiS Therapeutics
company
About
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $86M
- Industries
- Biopharma,Biotechnology,Genetics,Health Care,Machine Learning
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$86M
METiS Therapeutics has raised a total of
$86M
in funding over 2 rounds. Their latest funding was raised on
Dec 7, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2021 | Series A | $86M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
METiS Therapeutics is funded by 1 investors.
CMBI Zhaoxin Wuji Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
